Pre-Dilution vs. Post-Dilution during Continuous Veno-Venous Hemofiltration: Impact on Filter Life and Azotemic Control
Authors:
- Nigel FealyNFNigel Fealy
- Ian BaldwinIBIan Baldwin
- Hiroshi MorimatsuHMHiroshi Morimatsu
- Rinaldo BellomoRBRinaldo Bellomo
- 1 August 2003
- journal article
- research article
- Published by S. Karger AG in Nephron Clinical Practice
- Vol. 94 (4) , c94-c98
Abstract
Background/Aims: To determine the impact of replacement fluid infusion site on filter life and azotemic control during continuous veno-venous hemofiltration (CVVH). Methods:Pre-dilution CVVH was conducted from February 2001 to December 2001 and then practice was changed to post-dilution (from January 2002 to July 2002). Filter life was prospectively observed and the following data obtained for each filter: starting date and time, ending date and time, heparin use, heparin dose and protamine use. Daily creatinine, urea, INR, APTT and platelet count were also collected. Results: Forty-eight patients were studied (33 in pre-dilution and 15 in post-dilution) for a total of 309 filters (202 in pre-dilution and 107 in post-dilution). The median filter life was significantly shorter in the post-dilution period (18.0 vs. 13.0 h, p = 0.021). Multivariate linear regression analysis showed that pre-dilution was a significant independent predictor of increased filter life (p = 0.029), together with platelet count (p = 0.0035) and heparin dose (p = 0.046). There was no significant improvement in daily creatinine and/or urea reduction in the post-dilution period (% Δ creatinine: 7.9 vs. 10.2%/day, p = 0.99, urea: 5.4 vs. 9.7%/ day, p = 0.78). Conclusions: Post-dilution was associated with reduced filter life without any beneficial effect on daily changes in urea and creatinine levels. Pre-dilution appears a preferable technical approach to CVVH.Keywords
This publication has 8 references indexed in Scilit:
- Citrate anticoagulation in continuous venovenous hemodiafiltration: a metabolic challengeIntensive Care Medicine, 2002
- Continuous haemofiltration in acute renal failure with prostacyclin as the sole anti-haemostatic agentIntensive Care Medicine, 2002
- Epidemiology, management, and outcome of severe acute renal failure of critical illness in AustraliaCritical Care Medicine, 2001
- Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trialThe Lancet, 2000
- Nadroparin versus dalteparin anticoagulation in high-volume, continuous venovenous hemofiltration: A double-blind, randomized, crossover studyCritical Care Medicine, 2000
- A PROSPECTIVE STUDY OF THROMBOELASTOGRAPHY (TEG) AND FILTER LIFE DURING CONTINUOUS VENO-VENOUS HEMOFILTRATIONRenal Failure, 2000
- Inability of the activated partial thromboplastin time to predict heparin levels. Time to reassess guidelines for heparin assaysArchives of internal medicine (1960), 1997
- A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter studyJAMA, 1993